课题基金 / 基金详情

Molecular Endocannabinoid Mediators of Impaired Aversive Learning in Low Weight Eating Disorders

Molecular Endocannabinoid Mediators of Impaired Aversive Learning in Low Weight Eating Disorders
低体重饮食失调中厌恶学习受损的分子内源性大麻素调节剂
批准号:
9752085
负责人:
ANAT BIEGON
金额:
$26.28万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-04-16 至 2021-01-31

项目摘要

项目成果

ANAT BIEGON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project summary: Low weight eating disorders (LW-EDs), including anorexia nervosa and related atypical variants, are characterized by persistent food avoidance. Disturbances in behavior among individuals with LW-EDs persist beyond the acute starvation stage into the period of weight normalization, with abnormalities observed in food- cue learning, expectancies related to food, and food choice. We hypothesize that the persistence of disordered affect and food-cue learning result from an allostatic disruption of endocannabinoid (eCB) tone, as specifically evidenced by an upregulation of eCB1 receptors and an impaired responsivity and tone of eCBs. This proposal therefore aims to test this theory using the novel PET ligand [(18)F]MK-9470, a robust and reliable measure of brain eCB1 receptor availability in 6 women recently weight restored from a LW-ED and 6 age, gender, and body mass index matched control women. Participants will complete behavioral measures of food-cue learning and food choice, PET measures of CB1 receptor availability, time course changes in plasma eCBs to a palatable food challenge, and objective and subjective measures of eating behavior. We will: (1) model both region specific and whole brain measures of eCB1 receptor availability, and (2) test whether eCB1 receptor discriminates those with LW-EDs from healthy controls. Further, we will evaluate if this upregulation mediates impaired time course response of plasma eCBs to food challenge. Results from this study will provide critical data about the unique role of eCBs in pathological patterns of food choice and avoidance in those with LW- EDs. Successful completion of this study will offers a tangible and robust target for novel treatment intervention with pharmacological, nutritional, or combination therapeutics among those with LW-EDs.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular Endocannabinoid Mediators of Impaired Aversive Learning in Low Weight Eating Disorders
Neuroinflammation, NMDA receptors and cognitive function in chemobrain
Brain aromatase availability in steroid users: PET studies with [11C]vorozole
Brain aromatase availability in steroid users: PET studies with [11C]vorozole
海外基金